跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 76 条关于
“STARLIGHT”
全部
76
临床试验
50
药物
0
机构
2
资讯
24
上个月
Estrella Immunopharma Doses First Patient in STARLIGHT-1 Dose-Expansion Phase for EB103 ARTEMIS T-Cell Therapy in R/R B-Cell NHL
去年
Estrella Immunopharma Advances EB103 ARTEMIS T-Cell Therapy to Second Cohort in STARLIGHT-1 Trial for Advanced B-Cell Lymphomas
去年
Estrella Immunopharma's EB103 Shows Complete Response in B-Cell Lymphoma Trial
5个月前
FDA Clears Phase 1 Pediatric CNS Cancer Trial for STAR-001 Combination Therapy
去年
Estrella's EB103 Cell Therapy Shows Promising Safety Profile in NHL Trial's First Cohort
2年前
Nanoscope Therapeutics to Advance MCO-010 for Stargardt Disease to Phase 3 Trial Following FDA Meeting
10个月前
Estrella Immunopharma's EB103 Achieves 100% Complete Response Rate in High-Risk B-Cell Lymphoma Patients
去年
Lantern Pharma Reports Strong Clinical Results and AI Platform Advancements in 2024 Year-End Update
去年
Nanoscope to Present 126-Week Vision Restoration Data for MCO-010 Gene Therapy in Retinitis Pigmentosa
去年
Nanoscope Therapeutics Showcases MCO-010 Optogenetic Therapy Data at ASGCT 2025
第 1 页,共 3 页
上一页
下一页